About Sohang Chatterjee
Form D filings for Praesidia Biotherapeutics from 2021 to 2024 list Sohang Chatterjee as chief executive officer and director.
Sohang Chatterjee first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Sohang Chatterjee in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sohang Chatterjee works with at each company, as listed on that company's latest Form D.
Praesidia Biotherapeutics, Inc. · Form D/A, Jul 17, 2024